An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis

NCT05124080 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Nail Psoriasis

Interventions

DRUG: Deucravacitinib

Sponsor

University of Alabama at Birmingham